| Literature DB >> 34380736 |
Pau Castel1, Srisathiyanarayanan Dharmaiah2, Matthew J Sale1, Simon Messing2, Gabrielle Rizzuto3, Antonio Cuevas-Navarro1, Alice Cheng1, Michael J Trnka4, Anatoly Urisman3, Dominic Esposito2, Dhirendra K Simanshu5, Frank McCormick6.
Abstract
RAS proteins are molecular switches that interact with effector proteins when bound to guanosine triphosphate, stimulating downstream signaling in response to multiple stimuli. Although several canonical downstream effectors have been extensively studied and tested as potential targets for RAS-driven cancers, many of these remain poorly characterized. In this study, we undertook a biochemical and structural approach to further study the role of Sin1 as a RAS effector. Sin1 interacted predominantly with KRAS isoform 4A in cells through an atypical RAS-binding domain that we have characterized by X-ray crystallography. Despite the essential role of Sin1 in the assembly and activity of mTORC2, we find that the interaction with RAS is not required for these functions. Cells and mice expressing a mutant of Sin1 that is unable to bind RAS are proficient for activation and assembly of mTORC2. Our results suggest that Sin1 is a bona fide RAS effector that regulates downstream signaling in an mTORC2-independent manner.Entities:
Keywords: KRAS; RAS; RBD; Sin1; mTORC2
Mesh:
Substances:
Year: 2021 PMID: 34380736 PMCID: PMC8379911 DOI: 10.1073/pnas.2103261118
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205